Search

Vassilios I Avramis

from Oceanside, CA
Age ~74
Get Report
Also known as:
Vassilios Ioannis Avramis, Vassilios L Avramis, Vassilios A Avramis, Vassilios Avramis Phd
Related to:
Ellen S Gilley, 92Earl V Avramis, 37Susan A Avramis, 69Susan A AvramisIoanne A ArramisIoannis Arramis, 44Gilley J AvramisMaryalice Gilley
Connected to:
Daniela I Avramova, 61Dejan R Avramovich, 56Diana K Avramova, 53Dimitre S Avramov, 57Nebojsa Avramovic, 55Nikola A Avramovic, 76Rade Avramovic, 66Sergey A Avramov, 42Vesna Avramovska, 67Leon I Avren, 62

Vassilios Avramis Phones & Addresses

  • Oceanside, CA
  • Sacramento, CA
  • 13434 Aldergrove St, Sylmar, CA 91342 (818) 364-1009
  • Houston, TX
  • Los Angeles, CA
  • 13434 Aldergrove St, Sylmar, CA 91342 (818) 324-1260

Work

Position: Protective Service Occupations

Education

Degree: Graduate or professional degree

Professional Records

License Records

Vassilios I Avramis

Address:
15123 Loma Paseo Dr, Houston, TX
License #:
16713 - Expired
Category:
Health Care
Issued Date:
Jul 19, 1978
Effective Date:
Jan 1, 1901
Expiration Date:
Jun 20, 1985
Type:
Pharmacist

Publications

Us Patents

Composition And Methods For Treatment Of Hiv Infection

View page
US Patent:
20040228839, Nov 18, 2004
Filed:
Jan 20, 2004
Appl. No.:
10/760729
Inventors:
Vassilios Avramis - Sylmar CA, US
Lewis Cohen - Pottstown PA, US
International Classification:
A61K038/21
A61K031/551
A61K038/05
US Classification:
424/085700, 514/220000, 514/352000, 514/018000, 514/575000
Abstract:
Method of inhibiting or treating Human Immunodeficiency Virus (HIV) infection, comprising administering to a patient in need thereof an effective amount of a pharmaceutically acceptable composition comprising a PEG-ASNase compound or asparaginase, and optionally at least one compound selected from the group consisting of protease inhibitor compounds, ribonucleotide reductase inhibitor compounds and HIV reverse transcriptase inhibitor compounds.

Combinations Of (A) An Atp-Competitive Inhibitor Of C-Abl Kinase Activity With (B) Two Or More Other Antineoplastic Agents

View page
US Patent:
20090239878, Sep 24, 2009
Filed:
Apr 29, 2009
Appl. No.:
12/432029
Inventors:
Ioannis Alexander Avramis - Sylmar CA, US
Vassilios Ioannis Avramis - Sylmar CA, US
International Classification:
A61K 31/497
A61P 35/00
US Classification:
51425218
Abstract:
The invention relates to combinations of (a) an ATP-competitive inhibitor of c-abl kinase activity with (b) two or more other antineoplastic agents for simultaneous, separate or sequential use, in particular for the delay of progression or treatment of a proliferative disease

Composition And Methods For Treatment Of Hiv Infection

View page
US Patent:
6689762, Feb 10, 2004
Filed:
Aug 6, 1999
Appl. No.:
09/370390
Inventors:
Vassilios I. Avramis - Sylmar CA
Lewis Cohen - Pottstown PA
Assignee:
Enzon Pharmaceuticals, Inc. - Bridgewater NJ
International Classification:
A01N 4304
US Classification:
514 50, 514 49, 514 51
Abstract:
Method of inhibiting or treating Human Immunodeficiency Virus (HIV) infection, comprising administering to a patient in need thereof an effective amount of a pharmaceutically acceptable composition comprising a PEG-ASNase compound or asparaginase, and optionally at least one compound selected from the group consisting of protease inhibitor compounds, ribonucleotide reductase inhibitor compounds and HIV reverse transcriptase inhibitor compounds.
Control profile
Vassilios I Avramis from Oceanside, CA, age ~74 Get Report